Switch to:
GuruFocus has detected 4 Warning Signs with AbbVie Inc $ABBV.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
AbbVie Inc (NYSE:ABBV)
Capital Expenditure
$-453 Mil (TTM As of Mar. 2017)

Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

AbbVie Inc's cash flow for capital expenditures for the three months ended in Mar. 2017 was $-95 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2017 was $-453 Mil.


Definition

Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

AbbVie Inc Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2017 was -131 (Jun. 2016 ) + -113 (Sep. 2016 ) + -114 (Dec. 2016 ) + -95 (Mar. 2017 ) = $-453 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

AbbVie Inc Annual Data

Dec09Dec10Dec11Dec12Dec13Dec14Dec15Dec16
Cash Flow_CPEX 00-313-448-356-333-491-612-532-479

AbbVie Inc Quarterly Data

Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16Dec16Mar17
Cash Flow_CPEX -153-145-115-127-145-121-131-113-114-95
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK